Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
23.33
+1.35 (6.14%)
At close: Sep 5, 2025, 4:00 PM
23.05
-0.28 (-1.20%)
After-hours: Sep 5, 2025, 4:10 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.67 billion as of September 5, 2025. Its market cap has increased by 73.08% in one year.
Market Cap
1.67B
Enterprise Value
1.43B
1-Year Change
73.08%
Ranking
Category
Stock Price
$23.33
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.67B, an increase of 161.72%. That is a compound annual growth rate of 23.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 1.67B | 60.31% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |